期刊文献+

白藜芦醇苷及其代谢物在Beagle犬体内的排泄动力学研究 被引量:4

Study on the Excretion Pharmacokinetics of Polydatin and Its Metabolite in Beagle Dogs
下载PDF
导出
摘要 目的:研究白藜芦醇苷(TRG)及其代谢物在Beagle犬粪样中的代谢与排泄情况,为TRG的新药开发提供实验依据。方法:4只Beagle犬ig TRG 20%聚乙二醇400溶液50 mg/kg,采用液相色谱-质谱联用法鉴定TRG给药后12~24 h粪样中的代谢物,采用高效液相色谱法测定给药后0~12、12~24、24~36、36~48、48~72、72~96 h TRG在粪样中主要代谢物[其苷元白藜芦醇(TR)]以及TR累积排泄率及排泄速率。结果:在犬粪中可测到TR及TR的2个硫酸结合物,其中TR为主要代谢物,未测到TRG。TR在犬粪中排泄速率于给药后12~24 h时最大,达到9.65 mg/h;其累积排泄率为39.3%,相当于TRG给药剂量的67.2%。结论:犬ig TRG后,TRG主要以TR形式从粪中排出体外。 OBJECTIVE: To study the metabolite and excretion of polydatin (Trans-resveratrol-3-O-glucoside, TRG) and its metabolites in Beagle dog feces, and provide experimental basis for the new drug development of TRG. METHODS: 4 Beagle dogs were intragastrically administrated TRG 20% polyethylene glycol 400 solution 50 mg/kg. LC/MS was used to identify the me- tabolites of TRG in dog feces after 12-24 h of administration, and HPLC was adopted to determine the cumulative excretion rate and excretion speed rate of the major metabolite resveratrol (TR) in feces samples after 0-12, 12-24, 24-36, 36-48, 48-72, 72-96 h of administration. RESULTS: TR and two sulfate conjugates of TR were found in dog feces, and TR was a major metabolite, while TRG was undetermined. The excretion speed rate of TR in dog feces was the rapidest after 12-24 h of administration, reach- ing 9.65 mg/h. Its cumulative excretion rate was 39.3%, equivalent to 67.2% of TRG. CONCLUSIONS: After TRG is intragastri- cally administrated to dogs, TRG was mainly excreted in the form of TR via dog feces.
出处 《中国药房》 CAS 北大核心 2017年第25期3514-3517,共4页 China Pharmacy
关键词 白藜芦醇苷 白藜芦醇 粪便 代谢 排泄 Polydatin Resveratrol Dogs Feces Metabolism Excretion
  • 相关文献

参考文献5

二级参考文献38

  • 1李菁雯,陈祥龙,孟祥智.虎杖及其提取物的研究进展[J].中医药学报,2011,39(3):103-106. 被引量:41
  • 2舒仕瑜,王兴勇,卢仲毅.白藜芦醇苷对内毒素休克大鼠肺组织中磷脂酶A_2的影响[J].中国药学杂志,2004,39(7):512-514. 被引量:9
  • 3傅喆暾,张蓉,黄宝康,郑汉臣.天然植物中活性成分白藜芦醇的作用研究进展[J].现代中药研究与实践,2005,19(2):62-64. 被引量:21
  • 4齐辉,张勉,王峥涛.HPLC同时测定虎杖中4种成分的含量[J].中国中药杂志,2006,31(23):2003-2005. 被引量:23
  • 5阴建,中药现代研究与临床应用,1993年,425页
  • 6Philipp S, Akos S, Walter J, et al. Resveratrol and its ana- logs: defense against cancer, coronary disease and neuro- degenerative maladies or just a fad [J]. Mutat Res, 2008, 658(1/2) :68.
  • 7Cal C, Garban H, Jazirehi A, et al. Resveratrol and can- cer: chemoprevention, apoptosis, and chemoimmunosen- sitizing activities[J]. Curt Med Chem, 2003,3 (2) : 77.
  • 8Zhu XL, Xiong LZ, Wang Q, et al. Therapeutic time wi- ndow and mechanism of tetramethylpyrazine on transient focal cerebral isehemia/reperfusion injury in rats[J]. Neu- rosci Lett, 2009,449 ( 1 ) : 24.
  • 9Longa EZ, Weinstein PR, Carlson S, et al. Reversible mi- ddle cerebral artery occlusion without craniectomy in rats [J]. Stroke, 1989,20(1):84.
  • 10Jia J, Zhang X, HuYS, et al. Protective effect of tetraeth- yl pyrazine against focal cerebral ischemia/reperfusion in- jury in rats: therapeutic time window and its mechanism [J]. Thromb Res,2009,123(5) : 727.

共引文献28

同被引文献63

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部